| Literature DB >> 28801854 |
Paria Naseri1,2, Alireza Alihemmati2,3, Seyed Hossein Rasta4,5,6.
Abstract
Folliculogenesis is a cycle that produces the majority of oocyte. Any disruption to this cycle leads to ovulation diseases, like polycystic ovarian syndrome (PCOS). Treatments include drugs and surgery; lasers have also been used complementarily. Meanwhile, still there is no definite treatment for PCOS. This study investigated the photo-bio stimulation effect of near-infrared and red low-level laser on producing follicles and compared the result with result of using common drug, clomiphene. Therefore, the aim of this study was to propose the use of lasers autonomously treatment. So, there was one question: how do lasers affect folliculogenesis cycle in rat's ovary tissue? In this study, 28 rats were assigned to four groups as follows: control (CT), clomiphene drug (D), red laser (RL), and near-infrared laser (NIRL). Afterwards, 14 rats of RL and NIRL groups received laser on the first 2 days of estrous cycle, each 6 days, for 48 days. During treatment period, each rat received energy density of 5 J/cm2. Seven rats in D group received clomiphene. After the experiment, lasers' effects at two wavelengths of 630 and 810 nm groups have been investigated and compared with clomiphene and CT groups. Producing different follicles to complement folliculogenesis cycle increased in NIRL and RL groups, but this increase was significant only in the NIRL group. This indicates that NIRL increases ovarian activity to produce oocyte that certainly can be used in future studies for finding a cure to ovarian negligence to produce more oocyte and treat diseases caused by it like PCOS.Entities:
Keywords: Clomiphene drug; Folliculogenesis cycle; Near-infrared laser; Polycystic ovarian syndrome; Rat ovary tissue; Red laser
Mesh:
Substances:
Year: 2017 PMID: 28801854 PMCID: PMC5682863 DOI: 10.1007/s10103-017-2296-5
Source DB: PubMed Journal: Lasers Med Sci ISSN: 0268-8921 Impact factor: 3.161
Fig. 1a Laser irradiation: This image shows style of laser irradiation during the experiment. b Rat restrainer: this restrainer designed for this study. It is approved by Ethics and Research Committee of TUMS (code number: TBZMED.REC.1394.238)
Fig. 2Number of different follicles. a PF increase in two RL and NIRL group with equal ratio compared to D and CT group. b Increase ratio for PFM is not equal. There is little difference in increase ratio for NIRL and RL group compared with CT and D group apposite of PF number. c The changes of SF. It increases in NIRL group more than the other group. d The changes of GF. It increases by laser and drug intervention too, but there is not little difference between D and RL group opposites of NIRL. NIRL has the most increase in the number of GF
Histopathological parameter in ovary tissue
| Parameters | CT | D | RL | NIRL |
|---|---|---|---|---|
| PF | 0.75 ± 0.250 | 1.29 ± 0.286 | 2.60 ± 0.245* | 2.60 ± 0.600* |
| PFM | 1.33 ± 0.667 | 2.40 ± 0.400 | 3.20 ± 0.200* | 3.50 ± 0.289* |
| SF | 0.50 ± 0.500 | 1.43 ± 0.202 | 2.17 ± 0.307* | 3.00 ± 0.408*,** |
| GF | 0.67 ± 0.333 | 2.00 ± 0.447 | 2.57 ± 0.202* | 5.00 ± 0.548*,**,*** |
Data are presented as mean ± SD
C control, D clomiphene drug, RL red laser injection, NIRL near-infrared laser injection
*P < 0.05 as compared with control; **P < 0.05 as compared with drug group; ***P < 0.05 as compared with RL group
Fig. 3Sections of ovary: there are four parts in this picture. a The control picture with less than different follicles. b D group. There is an increase in the growth of different follicles compared to CT. c RL group which shows that an increase in growth of different follicles more the D and CT group. d The changes of NIRL samples which have the most increase in the number of different follicles
Fig. 4Level of different hormone. a An increase in level of FSH in D, RL, and NIRL groups compared to CT. The maximum increase is for NIRL group. b Level of LH increase by laser and drug intervention in which maximum increase is for RL group although lowest increase is in NIRL group. c An increase in level of E2 in D, RL, and NIRL groups compared to CT while there is not little difference between them. d Changes level of Pro in D, RL, and NIRL groups compared to CT. It decreases by intervention and the most decrease is in NIRL group
The parameter of hormone assay in ovary tissue
| Parameters | CT | D | RL | NIRL |
|---|---|---|---|---|
| FSH (IU/L) | 0.16875 ± 0.025174 | 0.15329 ± 0.052185 | 1.42025 ± 0.125126*,** | 3.87733 ± 0.771480*,**,*** |
| LH (IU/L) | 0.03725 ± 0.011898 | 0.40557 ± 0.098978* | 0.60867 ± 0.077197* | 0.09457 ± 0.018313**,*** |
| E2 (pg/mL)f | 11.900 ± 0.7000 | 18.917 ± 1.1453* | 17.120 ± 0.8120* | 18.086 ± 0.6588* |
| Pro (ng/mL)g | 29.6300 ± 1.57000 | 17.3050 ± 1.56769* | 19.1267 ± 2.64739* | 13.1760 ± 0.41589* |
Data are presented as mean ± SD
C control, D clomiphene drug, RL red laser intervention, NIRL near-infrared laser intervention, pg/mL 3.67 pmol/L, ng/mL 3.18 nmol/L
*P < 0.05 as compared with control; **P < 0.05 as compared with drug group; ***P < 0.05 as compared with RL group
Attenuation coefficient
| Wavelength (nm) |
|
| ln |
|
|
|---|---|---|---|---|---|
| 630 | 32.3 | 7.8 | 1.4209 | 1.26 | 1.12770 |
| 32.7 | 11.2 | 1.0715 | 1.1 | 0.97410 | |
| 31.6 | 8.7 | 1.2898 | 1.19 | 1.08387 | |
| 34.2 | 8.3 | 1.416 | 1.28 | 1.10625 | |
| 33.5 | 5.3 | 1.8438 | 1.51 | 1.22106 | |
| 32.1 | 10.2 | 1.1465 | 1.13 | 1.01460 | |
| Mean of | |||||
| 810 | 202 | 50 | 1.3962 | 1.36 | 1.026618 |
| 216 | 67 | 1.1706 | 1.1 | 1.064182 | |
| 188 | 61 | 1.1256 | 1.1 | 1.023273 | |
| 216 | 55 | 1.3679 | 1.28 | 1.068672 | |
| 219 | 67 | 1.1844 | 1.17 | 1.012308 | |
| 195 | 64 | 1.1141 | 1.04 | 1.07125 | |
| 218 | 69 | 1.1504 | 1.13 | 1.018053 | |
| Mean of | |||||
Measurement of six samples for red laser by 630 nm wavelength and seven samples for near-infrared laser by 810 nm wavelength
Fig. 5Attenuation coefficient. a The attenuation coefficient for red laser by 630 nm wavelength. b The attenuation coefficient for near-infrared laser by 810 nm wavelength